1 / 49

Role of Ayurveda in Cancer Management A profile and focus on R&D

Role of Ayurveda in Cancer Management A profile and focus on R&D . N.SRIKANTH ASSISTANT DIRECTOR CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES Department of AYUSH Ministry of Health & Family Welfare Government of India. Historical Account .

verdad
Download Presentation

Role of Ayurveda in Cancer Management A profile and focus on R&D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Role of Ayurveda in Cancer ManagementA profile and focus on R&D N.SRIKANTH ASSISTANT DIRECTOR CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES Department of AYUSH Ministry of Health & Family Welfare Government of India

  2. Historical Account • The earliest and foremost recordcould be cited in AtharvaVeda (2200 BC) (‘Apachi’ ) • Apachi or Apachit which refer to multiple lymph node swelling. • Similar description has been depicted during the period of Sushruta (400 BC) in his classic SushrutaSamhita. • Apachi or multiple lymph node swelling has been cited at different places viz. the neck, axilla and groin.

  3. Ayurvedic Concepts of Cancer Regulation Tissue Formation HEALTH - DISEASE Vs TISSUE PHYSIOLOGY Samahayogavahi or Homoeostasis : Tissue - Organ- System integration “Samahayogavahiyadha hi asminsareeraedatavah… ….vaishamagamanam hi ….. …… Vridhi- Hrasagamanam hi punardhatunam……….”

  4. Ayurvedic Concepts of Cancer Regulation Tissue Formation CONTROL LED BY TISSUE SPECIFIC REGULATORY FACTOR AGNI (dhatwagni (tissue level) & bhutagni (organ/gene level ) Regulation /Homoeostasis of Tissue Physiology Derangement in REGULATION /AGNI FUNCTION CANCER

  5. Ayurveda Understanding Malignant Disease • Superficial swellings - ARBUDA • Non-healing ulcers - ASADHYA VRANA • Malignancies of deeper structures - GULMA • Classified based on • clinical presentations • site of lesion • course • prognosis

  6. Cancer pathology : Ayurveda & contemporary correlates

  7. Ayurveda Understanding Malignant Disease • Can considered • as malignant Can be labeled as Clear malignancy • Possibility of • malignancy • cannot be • ruled out

  8. Ayurveda Understanding Malignant Disease

  9. Health Seeking attitude Role of Ayurveda in Cancer • The most prevalent users of Traditional Medicine are individuals who have • Incurable/ Refractory conditions • Non–life-threatening conditions that may be chronic viz. neurological disorders, arthritis etc. • The second largest group of users are those struggling with chronic, potentially life-threatening diseases, such as Cancer and HIV/AIDS etc

  10. Health Seeking attitude Role of Ayurveda in Cancer • Both groups turn to TM/AYUSH systems for a variety of reasons, such as • to improve immune functioning • to improve overall functioning, • to increase quality of life • to cope with side effects from conventional therapies, and • to relieve symptoms related to their illness.

  11. Management protocols • Systemic • SamshodhanChikitsa • Shaman Chikitsa • RasayanChikitsa • Local • Alep • Parisheka, • Abhyanga • Vimlapana • Agni Karma, • Kshara Karma • Lifestyle

  12. Formulations commonly used in cancer

  13. Ayurvedic Plants commonly used in cancer

  14. Ayurvedic plants commonly used in cancer

  15. Rasayana • Another Ayurvedic approach of treating is restoration and preservation of health • Improved tissue functions • Disease Specific effects • Symptom management • Improvement in QOL

  16. Rasayana Approach

  17. Possible attributes of Rasayana • PUSTIKARA NUTRITIVE • OJOVARDHAKA/ • BALAKARA IMMUNO MODULATORY/POTENT • MICRO NUTRIENT • AYUSHYA /AYUSKARA ANTIOXIDANT /ADAPTOGENIC • INDRIYA BALAPRADA SUPPORTS THE SENSORY ANDMOTOR SYSTEMS • SMRITIKARA MEMORY BOOSTER • VRISYA APHRODISIAC • VAYASTHAPANA ANTI AGEING ACTION

  18. Evidence Base • In vitro Screening of Ayurvedic herbs for anti-cancer activity • Clinical studies

  19. Clinical Studies • Stand Alone Ayurveda • Complementary to Conventional combinations • Clinical safety & efficacy • Improvement of quality of life • Overall survival • Event free survival • Progression free survival

  20. Intervention • Panchakarma (Snehan Karma with Triphala Ghrita as poorvakarma) • 6 months intervention with Ayurvedic drugs containing: • Bhallatak • Rohitak • Madhyasthi • Tamra Bhasma

  21. METHODOLOGY • Stand alone and add-on/adjuvant therapy to radio/chemo therapies • N=400 • Study period =10 years • Follow-up = 5years • Different types of Cancer • Different sites and stages

  22. treatment groups(n=400)

  23. Subjects and trial interventions

  24. Systemic involvement

  25. Histopathology

  26. Bio –constitution and Cancer Subjects

  27. Report on Follow-ups Years

  28. RESULTSOUTCOMES • Weight • Hb% • Glutamate Decarboxylase (GAD) Activity • Cytotoxic effects • Immune function • Survival and lifespan

  29. Body weight changes • When compared with other groups in those patients who received therapy of Ayurvedic drugs alone or in combination/adjuvant to radio therapy, chemotherapy or radiotherapy+ chemotherapy • Inhabited loss in body weight • Significant gain in weight

  30. Body weight changes

  31. Inhibited fall in Hemoglobin% • Increase in Hb% • The hemoglobin percentage has increased from 9.0 gm% to 11.0 gm% in combined therapy of radiation and Ayurvedic drug. • Whereas it has improved from 9.6 gm% to 12.2 gm% in combined therapy of chemotherapy and Ayurvedic drug. • Those patients treated with the combined therapy of radiation, chemotherapy and Ayurvedic drug reveal increase in hemoglobin percentage from 10.3gm% to 11.2 gm% after six months of treatment. • Similarly patients subjected to only Ayurvedic drug therapy at stage I and II also showed increase in hemoglobin percentage from 9.6 gm% to 12.7 gm%.

  32. Hb

  33. Glutamate Decarboxylase (GAD) Activity • Significant decrease in GABA and increase in glutamate in the blood was observed in all cancer subjects • The synthetic enzyme of GABA and degrading enzyme of glutamate i.e. glutamate decarboxylase (GAD) revealed significantly low activities.

  34. Glutamate Decarboxylase (GAD) ActivityChemotherapy

  35. Glutamate Decarboxylase (GAD) Activity Chemotherapy+Radiotherapy

  36. Glutamate Decarboxylase (GAD) ActivityChemotherapy + Ayurvedic drug

  37. Glutamate Decarboxylase (GAD) ActivityCHEMO+RADIO+AYURVEDIC DRUG

  38. SURVIVAL IN DIFFERENT GROUPS • Increase in survival % with addition of Ayurveda therapy to conventional treatments ranging from …65-76%

  39. SURVIVAL IN DIFFERENT GROUPS

  40. Summary • Ayurveda stand alone and as add-on/ adjuvant therapy to radio/chemo therapies have shown … • Significant increase in Hb% • Prevent fall in Hb% • Loss in body weight inhabited • Significant gain in weight • Increase in GAD levels • Increase in survival period • Improved immune status (IgA Levels) ………… when compared to radio/chemo therapies alone

  41. Biological activity and Ayurveda leads Leads on Anticancer Activity • Screening of Ayurvedic herbs for anti-cancer activity • Standardized Plant Extracts • Basis from Classical Literature • In vitro studies on cell lines • Potential leads • Scope for further Validation

  42. Leads on Anti Cancer activity* *Report on Screening of single Herbal drug extracts for potential anti-cancer activity; 2009, Central Council for Research Ayurveda & Siddha, New Delhi.

  43. Current Drug Trials

  44. A Way Forward Evidence base of Ayurveda can offer for global health • These modalities • Stand alone • As add on therapies are proven to have an edge over conventional medical approach in dealing with Chronic and refractory disease conditions sharing huge Global burden • The integration of AYUSH Systems with bio-medicine should be a symbiosis without losing their own core fundamentals and this approach could possibly provide a solution for the benefit of cancer subjects

  45. Thank you

More Related